chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A nurse reported that a 55 year old female received an injection of Flu Shield (1998-1999 Formula). Subsequently, she developed an injection site reaction characterized by redness, soreness and warmth which extended to her elbow. The symptoms resolved in 5 days. This pt developed an injections site reaction following receipt of Flu Shield (1999-2000 Formula) and Flu Shield (2000-2001 Formula). See HQ8940328NOV2001 and HQ9179606DEC2001.
Lymph nodes on left side are swollen.  When extending arm upwards (hand above my head), I can see a bump right under my armpit.  Bump is probably 3" diameter and approximately .75" in thickness (as thick as my fingers, not as thick as the palm of my hand).  It's tender to the touch, but not painful.   Lymph nodes on right side do not seem to be affected.
From initial information received on 1/30/03, it was reported that a 40 year old male patient received TD ADS ADULT (lot number U0824AA) given IM in the left deltoid on 1/15/03. On 1/16/03, the patient experienced redness and swelling, the size of a grapefruit, at the injection site. The patient also experienced a fever of 101 degrees, decreased appetite, chills for 3 days and joint pain. The patient reportedly recovered from these events. This case is closed.
There was no adverse reaction. Pt is new to our practice. His old records indicated that he had not received a Menactra. Apparently, it was in a hopsital record that he had recieved one less than 1 year ago.I spoke to the state epidemiologist who recommended I file an adverse reaction report .
Information has been received from a nurse practitioner concerning a 14 year old male patient with overweight and asthma who on 12-AUG-2005 was vaccinated with a first dose of VARIVAX (Merck) (Lot# unknown). Second dose of VARIVAX (Merck) (Lot# 666368/0227Z) was given on 17-AUG-2010. The nurse reported that about 16 days after patient's first vaccination with VARIVAX (Merck) in approximately 28-AUG-2005, he developed "possible chickenpox vs. VARIVAX (Merck) reaction" and had an asthma attack. His mother called it "full blown chickenpox". On 19-AUG-2010, after his second vaccination the patient developed a "golf ball size knot" and redness at the injection site which was being treated with BENADRYL, MOTRIN and ice. The patient's outcome regarding possible chickenpox vs VARIVAX (Merck) reaction and asthma attack was not reported. At the time of the report, the patient had not recovered from golf ball size knot and redness at the injection site. The patient sought medical attention. Additional information has been requested.
Per pt, experienced symptoms of the flu (tiredness, fever, pain, lethargy, chills)
Felt lymph node under left arm on; Felt like she was getting sick; Mild chills; Dizzy; Felt fatigued; Super sleepy; Really tired; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Super sleepy), MALAISE (Felt like she was getting sick), CHILLS (Mild chills), DIZZINESS (Dizzy) and LYMPHADENOPATHY (Felt lymph node under left arm on) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Morphine allergy).    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced SOMNOLENCE (Super sleepy) and FATIGUE (Really tired). On 12-Mar-2021, the patient experienced MALAISE (Felt like she was getting sick), CHILLS (Mild chills), DIZZINESS (Dizzy) and FATIGUE (Felt fatigued). On 14-Mar-2021, the patient experienced LYMPHADENOPATHY (Felt lymph node under left arm on). At the time of the report, SOMNOLENCE (Super sleepy), MALAISE (Felt like she was getting sick), CHILLS (Mild chills), DIZZINESS (Dizzy), LYMPHADENOPATHY (Felt lymph node under left arm on), FATIGUE (Really tired) and FATIGUE (Felt fatigued) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Mom reports about 2 pm 10/01/2001 child started vomiting and running fever, 101 (R), legs swollen on injection sites. States gave Tylenol and used cold compresses on legs. Called Dr. brought on by Hib Vaccine causing reaction. She called ER. On 10/05/2001 vomiting, fever.
Information has been received from a physician and a practice manager via a company representative referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 15-JUL-2016, the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB 5 mcg/0.5 ml, lot # L045117 and expiration date 06-OCT-2018 (administration route was not provided). No adverse effects were reported. The vaccine had two temperature excursions, both of 144 hours with a lowest recorded temperature of 32 Fahrenheit (F) (0 Celsius (C)) and for the other a lowest recorded temperature of 34 Fahrenheit (F) (1.111111111 Celsius (C)). The storage criteria and the type of excursion for this vaccine was refrigerator (R). This is one of several reports received from the same source. Additional information has been requested.
1 bullae on L chest developed 8-10 hrs after the L deltoid injection.
Initial onset were symptomatic of CVA. Patient seen at emergency department and diagnosed with Bells Palsy. Patient continues to c/o symptoms consistent with Bells Palsy.
I received the Moderna Bivalent AS7162B Vaccine 9-14-22 at the public health clinic. Within days I began experiencing hoarseness and coughing. A key symptom date was 10-10-22. For several years I have checked and recorded blood pressure and pulse rates twice a day. On 10/10/22 my pulse rate made a notable increase. For purposes of comparison, I averaged the pulse rate for 15 days (30 readings) immediately preceding 10-10-22. That average was 73. I then measured pulse ratings for 15 days (30 readings) starting with 10-10-22. That average was 83.   My symptoms (inability to sing, pray audibly, or read out-loud or any other strenuous use of my voice without intense coughing) progressed to the point I made an appointment with my primary care physician for 10-20-22. He ran an EKG and a chest x ray. The chest x-ray was clear, but the EKG revealed a Left Bundle Branch Blockage, which had not been noted on any earlier EKGs.  I returned for a follow-up on 10-25-22 for another meeting with Dr. at which time he provided me with the contact information to report this Vaccine Adverse Event. He has also placed in motion additional follow-ups with specialists.
Information has been received from a registered nurse (R.N.) concerning a 36-month-old white male (31 lb., 38 in.) with no pre-existing allergies, birth defects or medical conditions, who on 27-OCT-2004 was vaccinates subcutaneously in the arm with a first dose of Varivax (lot# 648757/0594P). Concomitant vaccination included a first dose of MMR (lot# 648144/0042P) given subcutaneously in the arm on 27-OCT-2004 and a first dose of FLUZONE (lot# U1442AA) given intramuscularly in the arm on 23-OCT-2004. There was no illness at the time of vaccination. There was no rash at the injection site or elsewhere within 42 days of the vaccination. On 05-AUG-2006 the patient developed a cluster of blisters on his left shoulder with a sharp border medially. He was seen by a physician and diagnosed with shingles. It was reported that there was no history of chickenpox or exposure to chickenpox or herpes zoster. No laboratory or diagnostic tests were performed. It was reported that the patient had no pain and was treated with acyclovir for five days. At the time of this report the patient recovered. Additional information has been requested.
After taking the first shot I broke out in house; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single for Covid-19 immunisation. The patient's medical history and concomitant medications were not reported. It was reported that 9 days after taking the first shot on an unspecified date, the patient broke out in the house. The outcome of the event was unknown.   No follow-up attempts are possible; information about batch/lot number cannot be obtained. No further information is expected.
11/15/21 presents to ED ED for "SOB on exertion. O2 sat dropping to low 80s w/ ambulation. Frequent coughing w/ chest pain". PMHx of "COPD, CVID, hypothyroidism, and CVA".
This patient states he woke up on 09/24/00 with a "lump" under his right arm and sore to move. No SOB, rash, or other symptoms, sickness or complaints. Able to touch top of head with that arm; 4-5 cm lymph node noted and right arm. No history of adverse reaction to shots in the past. Complains of cat in the house patient with a scratch.
red hot skin surrounding site, approx 6 inches long above and below shot area, advised patient to visit urgent care located inside pharmacy to see the nurse practioner for an antibiotic to treat a skin infection, patient immediately saw the NP and received Keflex 500 mg script filled, and picked up by patient to begin taking tonight 10/6/19
Initial case was retrieved from scientific literature on 19 July 2010. A young female patient (age not reported), with medical history not reported, received an injection (date, route and site not provided) of influenza vaccine, lot number not reported. "Within thirty minutes the woman lost consciousness while driving, causing her to lose control of her motor vehicle. She suffered severe injuries and was hospitalized for six weeks. During that time her gallbladder and a kidney were removed. She also suffered a colon injury, a lacerated liver, a fractured arm and multiple left foot and ankle fractures, which left her with a permanent limp. The patient sued and claimed that the loss of consciousness was from a vasovagal reaction to the vaccination. An expert witness stated this type of reaction was "not uncommon" and was a "universally-recognized potential complication." The outcome for the events were not reported. Editor's Comments: Details of this case are missing. The medical staff has an obligation to observe the patient after an injection for a reasonable period of time. In this case, it is hard to imagine that a vasovagal reaction could occur so long (30 minutes) after the injection. Perhaps the expert witness testimony should be scrutinized. Documents held by sender: None.
My brain function feels sluggish all the time now.; I started to feel a loss of energy; body aches/mild ache from my head to my toes, in my muscles and bones; confusion; complete change in appetite.; dizziness; feels like I'm overheating.; mild ache from my head to my toes, in my muscles and bones; mild ache from my head to my toes, in my muscles and bones; This is a spontaneous report from a contactable consumer. A 55-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included none from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Historical Vaccine BNT162B2 product: COVID 19, brand: Pfizer, lot number: EM9810, lot unknown: False administration date09Feb2021 administration time:11:15 PM dose number:1 vaccine location: Left arm for COVID-19 immunisation. Patient has no known allergies. Patient was not tested covid prior vaccination ,Not tested covid prior vaccination. On 07Mar2021 07:00 adverse event:  After receiving the 2nd dose/shot, within 4-5 days, Patient started to feel loss of energy, body aches, confusion, complete change in Her brain function feels sluggish all the time now. Patient have a mild ache from her head to my toes, in muscles and bones that never goes away, constant dizziness, and a feeling of being just under the weather. It's been 5 months since patient received the 2nd shot, and she haven't felt the same since. Patient struggle to make it through each day, her demeanor has changed alot from who she was prior to receiving the vaccine. Patient never feel well enough to do the things she used to do on a weekly/daily basis, like mountain climbing, swimming, and hikes. Her body always feels like I'm overheating. Patients want to be me again so badly, she hates being, and feeling like this every day. She feels like I just got off a bad carnival ride, and can't get that normal feeling back. After 5 months, someone needs to know what I've been going through because, it's not going away. The Outcome of events was not recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
ITCHY; RED; RASH THAT IS SPREADING ALL THE BODY LIKE FOREHEAD, EAR AND ARM; itchy, rash; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (ITCHY), VACCINATION SITE ERYTHEMA (RED), RASH (RASH THAT IS SPREADING ALL THE BODY LIKE FOREHEAD, EAR AND ARM) and RASH PRURITIC (itchy, rash) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History was provided by the reporter.   On 18-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 18-Feb-2021, the patient experienced PRURITUS (ITCHY), VACCINATION SITE ERYTHEMA (RED), RASH (RASH THAT IS SPREADING ALL THE BODY LIKE FOREHEAD, EAR AND ARM) and RASH PRURITIC (itchy, rash).   The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency.   At the time of the report, PRURITUS (ITCHY), VACCINATION SITE ERYTHEMA (RED), RASH (RASH THAT IS SPREADING ALL THE BODY LIKE FOREHEAD, EAR AND ARM) and RASH PRURITIC (itchy, rash) outcome was unknown.      Concomitant product use was not provided by the reporter.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. In 2014, the patient was inoculated with the ZOSTAVAX vaccine at a pharmacy as recommended for routine adult health maintenance and for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain of herpes zoster. In 2016, the patient was treated at a medical facility by a physician for a blistering vesicular outbreak, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Additional information has been requested.
Pt developed a spontaneous spinal leak of CSF at the upper thoracic area approximately 19 months ago. Although she has not been headache free since April 2003, and she has had multiple exacerbations and moderations of symptoms, she has recently been able to function in her professional role. She notes that frequently if she gets a cough or a cold she will find that the illness aggravates and irritates her spinal symptoms. In an effort to protect herself from the thoracic strain that would result if she were to contract influenza, and because she is an active pediatrician with probable exposure, she received an influenza immunization with Fluzone on November 5, 2004. Seven days later she awoke in her usual state of health, and then at 9am experienced a sudden worsening of squeezing facial pain, much more severe than in months, with reappearance in cervical and thoracic areas of bone pain, as well as a deeper pain between her shoulder blades. She had not coughed or done any activities that might have caused a new leak.
Initially developed pain and itching at the injection site. Over the next several days, developed a circular rash at injection site and scattered rash to upper arm and other body sites. Injection site has been tender to touch since.
Headache the first day, on second day: chills progressing to fever, worsening headache, foggy mental status, soreness all over, fatigue
severe chills and perspiration at night during this period.; muscle/joint aches and pain in legs; muscle/joint aches and pain in legs; severe chills and perspiration at night during this period.; fever (up to 101.4F); Initial information received on 12-Jan-2021 regarding an unsolicited valid non-serious case received from a consumer.  This case involves a female patient who experienced severe chills and perspiration at night during this period. (night sweats), muscle/joint aches and pain in legs (arthralgia), (pain in extremity), fever (up to 101.4f) (pyrexia), while she received vaccine INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT].  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided.   Concomitant medications were unknown.  In September 2020, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE lot number not reported via intramuscular route in unknown administration site for prophylactic vaccination.  On 02-Oct-2020 both SARS-CoV-2 test and flu tests were negative.  On 12-Jan-2021, the patient developed severe chills and perspiration at night during this period. (night sweats), muscle/joint aches and pain in legs (arthralgia), (pain in extremity), fever (up to 101.4f) (pyrexia) approximately 4 months following the administration of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE.  She reports use of walker, but noticed needing to steady self a little more before she could walk since receiving vaccine. Caller states she normally does not use walker in the house, but states she has needed to use it more due to muscle aches/pain. Caller reports only one other reaction to a medication in her lifetime which was Lisinopril. Caller states that Lisinopril also caused severe muscle pain in which she had to go to physical therapy due to limited movement. Caller reports starting CoQ10 about a week ago as directed by PCP. Caller reports improvement in muscle pain since starting.  It was not reported if the patient received a corrective treatment.  The outcome was reported as Unknown for all events.  There will be no information available on the batch number for this case.
Patient was recommended to stay closer about 15 min after shot. He decided to stay inside his car with his fiancee at the parking lot. His fiancee came back to pharmacy stating patient had the possible allergic or anxiety reactions, including swelling, pale, and throwing up. They called 911 and ambulance came and check out his blood pressure and EKG. Patient stated feeling fine and refused to go to ER. She came to pharmacy for help after ambulance left. Patient received the epi pen on site. Patient was recommended to follow up with his PCP or ER or nearby walk-in clinic. Patient stated he felt sick the first time he had tatoo in the past. He did not eat anything that day. He stated felling better and would see a doctor if needed.
My wife & I have been affected in our joints. We have pain & are going for therapy & medication & injections.
0715 PATIENT RECIEVING THE ABOVE VACCINE HAD WHELTS ON FACE & HEAD, BENADRYL GIVEN. 13:35 PATIENT RETURNS WITH WHELTS AND RASH ALL OVER BODY. BENADRYL AND EPI GIVEN, TRANSFERRED TO VA HOSPITAL.
5 minutes after MENACTRA was given, she started crying. Localized redness noted at the injection which started to spread to elbow; also noted tingling and itching.
Patient reports swelling of eyelids that occured the day after the vaccination and lasted for about 1.5 days.
My physician strongly recommended I get the Gardasil vaccine even though I have been married for 6 years and completely monogamous. She also knew I was trying to get pregnant. One week after I got the vaccine I found out I was pregnant and one week after that I miscarried. I already have had a successful pregnant so there was no reason for my miscarriage. I strongly feel that it was related to the vaccine. I did go on to have another successful pregnancy 5 months after the vaccine.
I got the Pfizer vaccine, the first shot; I tested positive for Covid; I got the Pfizer vaccine, the first shot; I tested positive for Covid; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EH9899), via an unspecified route of administration on 18Dec2020 at single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported.  Consumer stated, "I had a question, I got the Pfizer vaccine, the first shot on the 18Dec but I tested positive for Covid on the 27Dec, so, my question is this and I asked my healthcare institution and they still haven't got back to me, so I just wanted to call you guys, what do I do about the second dose because I am scheduled to get the second dose net week?" The outcome of event was unknown.
Chills; Fever; Headache; This spontaneous case was reported by a nurse and describes the occurrence of CHILLS (Chills), PYREXIA (Fever) and HEADACHE (Headache) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced CHILLS (Chills), PYREXIA (Fever) and HEADACHE (Headache). In February 2021, CHILLS (Chills), PYREXIA (Fever) and HEADACHE (Headache) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. Treatment medications were unknown.  The patient received both scheduled doses of mRNA-1273 prior to the events therefore, action taken with the drug in response to the events was not applicable.
States injection site was red and raised and extensive area around site was red. Was also painful. Had diarrhea following day-not sure if linked or if viral. Also had temp on day but only overnight.
Leg pain/rash, hand pain/rash Pt treated with Morphine in ER Seen in dr office today & treated with Prednisone for continued symptoms
Myalgias and arthralgias. Pt went to urgent care and exam normal. She's feeling much better.
Headache, fatigue, nausea and vomiting, hot flashes/chills from about 2am the night after the shot until about 5pm
First of all I started getting a sore arm that evening, but around 3 in the morning I woke up with chills and aches, I was freezing and miserable, I was just shaking, because I had a bad fever, my husband got up and got me a blanket and Ibuprofen, the next morning I woke up and took my temp, and it was at 101.9 just under 102. I ran a temp for several days, probably like 5 days or so. I just treated it with medicine and juice and water.